Prostate and breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Prostate Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Axilla Mammary Glands, Human Neoplastic Stem Cells Epithelial Cells Lymph Nodes Nipples Neoplastic Cells, Circulating Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases43

Breast Neoplasms Carcinoma, Ductal, Breast Prostatic Neoplasms Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Neoplasms, Hormone-Dependent Genetic Predisposition to Disease Carcinoma Carcinoma, Lobular Disease Progression Carcinoma, Intraductal, Noninfiltrating Neoplasm Recurrence, Local Lymphatic Metastasis Mammary Neoplasms, Experimental Ovarian Neoplasms Bone Neoplasms Adenocarcinoma Prostatic Hyperplasia Neoplasms Lung Neoplasms Fibrocystic Breast Disease Cell Transformation, Neoplastic Colonic Neoplasms Carcinoma, Ductal Carcinoma in Situ Neoplasms, Second Primary Stomach Neoplasms Prostatic Intraepithelial Neoplasia Triple Negative Breast Neoplasms Neovascularization, Pathologic Inflammatory Breast Neoplasms Neoplastic Cells, Circulating Pancreatic Neoplasms Fibroadenoma Uterine Cervical Neoplasms Neoplasms, Basal Cell Colorectal Neoplasms Neoplasms, Radiation-Induced Endometrial Neoplasms Neoplasms, Multiple Primary Urinary Bladder Neoplasms

Chemicals and Drugs60

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Prostate-Specific Antigen Antineoplastic Agents Neoplasm Proteins Receptors, Androgen RNA, Messenger Estrogens Estrogen Receptor alpha Androgens BRCA2 Protein BRCA1 Protein DNA, Neoplasm Aromatase Inhibitors Estrogen Antagonists RNA, Small Interfering Androgen Antagonists Estradiol Nitriles Fluorouracil Antibodies, Monoclonal, Humanized Tumor Suppressor Protein p53 Anticarcinogenic Agents Cyclophosphamide Antibodies, Monoclonal Antigens, Neoplasm Estrogen Receptor Modulators Selective Estrogen Receptor Modulators Epirubicin RNA, Neoplasm Tumor Suppressor Proteins Ki-67 Antigen Cancer Vaccines Receptor, Epidermal Growth Factor Paclitaxel Transcription Factors Proto-Oncogene Proteins c-akt MicroRNAs DNA-Binding Proteins Antigens, CD24 Mucin-1 Triazoles Antibiotics, Antineoplastic PTEN Phosphohydrolase Taxoids Proto-Oncogene Proteins Antineoplastic Agents, Phytogenic Anthracyclines Dihydrotestosterone Cyclin D1 Nuclear Proteins DNA Primers Cadherins Protein-Serine-Threonine Kinases Doxorubicin Tosyl Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Mammography Prognosis Neoplasm Staging Risk Factors Early Detection of Cancer Mastectomy Case-Control Studies Chemotherapy, Adjuvant Immunohistochemistry Survival Analysis Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Risk Disease-Free Survival Follow-Up Studies Prospective Studies Survival Rate Mammary Neoplasms, Experimental Breast Self-Examination Risk Assessment Retrospective Studies Incidence Treatment Outcome Xenograft Model Antitumor Assays Odds Ratio Blotting, Western Neoplasm Transplantation Cohort Studies Transplantation, Heterologous Sensitivity and Specificity Neoplasm Grading Prostatectomy Mastectomy, Segmental Multivariate Analysis Oligonucleotide Array Sequence Analysis Registries Tissue Array Analysis Tumor Burden Predictive Value of Tests SEER Program Biopsy, Needle Logistic Models Mass Screening Kaplan-Meier Estimate Transfection Questionnaires Combined Modality Therapy Reproducibility of Results Ultrasonography, Mammary Biopsy Orchiectomy Polymerase Chain Reaction Immunoenzyme Techniques Confidence Intervals Breast Implants Radiotherapy Proportional Hazards Models Transurethral Resection of Prostate Drug Screening Assays, Antitumor Radiotherapy, Adjuvant Clinical Trials as Topic Molecular Targeted Therapy Neoadjuvant Therapy Gene Knockdown Techniques Mammaplasty In Situ Hybridization, Fluorescence Drug Administration Schedule Genetic Testing Models, Biological Sentinel Lymph Node Biopsy Lymph Node Excision Estrogen Replacement Therapy DNA Mutational Analysis Flow Cytometry Radiotherapy Dosage Mastectomy, Radical

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Genes, BRCA1 Genetic Predisposition to Disease Cell Proliferation Postmenopause Drug Resistance, Neoplasm Risk Breast Feeding Premenopause Apoptosis Menopause Odds Ratio Genes, BRCA2 Signal Transduction Time Factors Sensitivity and Specificity Genes, erbB-2 Cell Division Mutation Cell Movement Down-Regulation Genotype Cell Growth Processes Transfection Promoter Regions, Genetic Polymorphism, Genetic DNA Methylation Germ-Line Mutation Cell Cycle Up-Regulation Dose-Response Relationship, Drug RNA Interference Cell Survival Gene Amplification Gene Silencing Gene Expression Genes, Tumor Suppressor Base Sequence Phosphorylation Phenotype Genes, Neoplasm Parity Polymorphism, Single Nucleotide Alleles Epithelial-Mesenchymal Transition Diet Transcription, Genetic Genes, p53 Drug Synergism Heterozygote

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care32

Risk Factors Case-Control Studies Survival Analysis Risk Disease-Free Survival Follow-Up Studies Prospective Studies Survival Rate Risk Assessment Retrospective Studies Incidence Treatment Outcome Age Factors Odds Ratio Cohort Studies Sensitivity and Specificity Multivariate Analysis Registries Predictive Value of Tests SEER Program Logistic Models Mass Screening Kaplan-Meier Estimate Questionnaires Reproducibility of Results Confidence Intervals Proportional Hazards Models Clinical Trials as Topic Genetic Testing Parity National Cancer Institute (U.S.)Age of Onset

Geographicals3

United States China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Breast Breast Neoplasms Carcinoma, Ductal, Breast Cell Line, Tumor Receptors, Estrogen Gene Expression Regulation, Neoplastic Receptor, erbB-2 Prostatic Neoplasms Breast Diseases Neoplasm Metastasis Tamoxifen Receptors, Progesterone Tumor Markers, Biological Neoplasm Invasiveness Mammography Prognosis Antineoplastic Agents, Hormonal Prostate-Specific Antigen Neoplasm Staging Risk Factors Antineoplastic Agents Early Detection of Cancer Breast Neoplasms, Male Neoplasm Proteins Neoplasms, Hormone-Dependent Mice, Nude Tumor Cells, Cultured Mastectomy Case-Control Studies Genes, BRCA1 Genetic Predisposition to Disease Cell Proliferation Chemotherapy, Adjuvant Postmenopause Immunohistochemistry Carcinoma Carcinoma, Lobular Drug Resistance, Neoplasm Survival Analysis Disease Progression Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction MCF-7 Cells Carcinoma, Intraductal, Noninfiltrating Antineoplastic Combined Chemotherapy Protocols Risk Receptors, Androgen Neoplasm Recurrence, Local RNA, Messenger Disease-Free Survival Estrogens Follow-Up Studies Estrogen Receptor alpha Breast Feeding Lymphatic Metastasis Premenopause Androgens Prospective Studies Survival Rate Mammary Neoplasms, Experimental Ovarian Neoplasms Breast Self-Examination Bone Neoplasms Risk Assessment Apoptosis Retrospective Studies Adenocarcinoma Prostatic Hyperplasia BRCA2 Protein Incidence Neoplasms Treatment Outcome Xenograft Model Antitumor Assays Age Factors Menopause Odds Ratio Genes, BRCA2 Signal Transduction BRCA1 Protein Lung Neoplasms Blotting, Western Survivors DNA, Neoplasm Neoplasm Transplantation Cohort Studies Aromatase Inhibitors Estrogen Antagonists Fibrocystic Breast Disease Transplantation, Heterologous Time Factors Sensitivity and Specificity RNA, Small Interfering Neoplasm Grading Prostatectomy Mastectomy, Segmental Axilla Genes, erbB-2 United States Cell Division

No FAQ available that match "prostate and breast cancer"